We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Fapon Biotech Presents Latest IVD Innovations at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 09 Feb 2023
Print article
Image: IVD raw materials and reagent services featured at Medlab Middle East 2023 (Photo courtesy of Fapon)
Image: IVD raw materials and reagent services featured at Medlab Middle East 2023 (Photo courtesy of Fapon)

Fapon Biotech (Guangdong, China) is presenting its latest IVD innovations at the 22nd edition of Medlab Middle East Congress taking place live, in-person from 6-9 February 2023.

As a leading supplier of IVD raw materials and customized solutions, Fapon has continuously developed and optimized its product portfolio to accelerate disease testing for downstream diagnostic companies. Fapon provides over 1300 antibodies, antigens, enzymes, blockers, and more on different technology platforms of chemiluminescence, ELISA, rapid test, immunoturbidimetry, PCR and NGS. At Medlab Middle East 2023, Fapon is introducing its wide range of raw materials and reagent services, such as cardiac marker, tumor marker, respiratory disease, inflammatory marker, tropical disease, infectious disease, drug of abuse, polymerase & mix, reverse transcriptase & mix, LAMP polymerase, PCR miscellaneous, and many more.

Fapon is also presenting its self-developed series of high-performance chemiluminescence immunoassay analyzers that are open and fully customizable. This includes Shine i1000, the smallest fully automatic chemiluminescence immunoassay analyzer, as well as the Shine i2000 compact yet robust and large capacity IVDR certified analyzer which is compatible with AE, AP, HRP, ABEI protocols. In addition, Fapon is showcasing the P810 real-time PCR analyzer and the iCatch2000 rapid molecular point-of-care analyzer. Equipped with Fapon’s core raw materials and reagent services, these instruments provide a one-stop solution for chemiluminescence immunoassay and ultra-fast PCR, respectively.

Related Links:
Fapon Biotech

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more